These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 32374770)

  • 1. Impact of prognostic nutritional index on outcomes in patients with Mycobacterium avium complex pulmonary disease.
    Moon SW; Lee EH; Choi JS; Leem AY; Lee SH; Lee SH; Kim SY; Chung KS; Jung JY; Park MS; Kim YS; Kang YA
    PLoS One; 2020; 15(5):e0232714. PubMed ID: 32374770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
    Ye JJ; Wu TS; Chiang PC; Lee MH
    J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Prognosis and Antimycobacterial Glycolipid Antibody as Biomarker in Mycobacterium avium-intracellulare Complex Pulmonary Disease.
    Maekura R; Miki K; Tateishi Y; Matsumoto S; Kitada S; Miki M; Kida H
    Microbiol Spectr; 2022 Jun; 10(3):e0053022. PubMed ID: 35467367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease.
    Gochi M; Takayanagi N; Kanauchi T; Ishiguro T; Yanagisawa T; Sugita Y
    BMJ Open; 2015 Aug; 5(8):e008058. PubMed ID: 26246077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
    Adachi Y; Tsuyuguchi K; Kobayashi T; Kurahara Y; Yoshida S; Kagawa T; Hayashi S; Suzuki K
    J Infect Chemother; 2020 Jul; 26(7):676-680. PubMed ID: 32171660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a prognostic scoring model for Mycobacterium avium complex lung disease: an observational cohort study.
    Kumagai S; Ito A; Hashimoto T; Marumo S; Tokumasu H; Kotani A; Yamaki H; Shirata M; Furuuchi K; Fukui M; Ishida T
    BMC Infect Dis; 2017 Jun; 17(1):436. PubMed ID: 28629426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of
    Hwang JA; Kim S; Jo KW; Shim TS
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28275170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
    Kadota T; Matsui H; Hirose T; Suzuki J; Saito M; Akaba T; Kobayashi K; Akashi S; Kawashima M; Tamura A; Nagai H; Akagawa S; Kobayashi N; Ohta K
    BMC Infect Dis; 2016 Jan; 16():31. PubMed ID: 26818764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium avium Complex: Addressing Gaps in Diagnosis and Management.
    Daley CL; Winthrop KL
    J Infect Dis; 2020 Aug; 222(Suppl 4):S199-S211. PubMed ID: 32814943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sputum quality on Mycobacterium avium-intracellulare complex lung disease diagnosis and treatment initiation according to disease type.
    Yoshida S; Tsuyuguchi K; Kobayashi T; Shimatani Y; Inoue Y
    Diagn Microbiol Infect Dis; 2022 Nov; 104(3):115773. PubMed ID: 35985099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Amikacin liposome inhalation suspension for refractory Mycobacterium avium complex pulmonary disease at 6 months post initiation.
    Urabe N; Sakamoto S; Tokita N; Yoshida H; Usui Y; Shimizu H; Sekiya M; Miyoshi S; Nakamura Y; Isobe K; Kishi K
    BMC Pulm Med; 2024 Sep; 24(1):442. PubMed ID: 39256717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association Between Sputum Culture Conversion and Mortality in Cavitary Mycobacterium avium Complex Pulmonary Disease.
    Lee JK; Kim S; Chong YP; Lee HJ; Shim TS; Jo KW
    Chest; 2024 Sep; 166(3):442-451. PubMed ID: 38508335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease.
    Hayashi M; Takayanagi N; Kanauchi T; Miyahara Y; Yanagisawa T; Sugita Y
    Am J Respir Crit Care Med; 2012 Mar; 185(5):575-83. PubMed ID: 22199005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease.
    Kim HJ; Lee JS; Kwak N; Cho J; Lee CH; Han SK; Yim JJ
    BMC Pulm Med; 2019 Nov; 19(1):212. PubMed ID: 31711459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of recurrence after successful treatment of Mycobacterium avium complex lung disease.
    Min J; Park J; Lee YJ; Kim SJ; Park JS; Cho YJ; Yoon HI; Lee CT; Lee JH
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1239-45. PubMed ID: 26459540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic impact of malnutrition in patients with severely decompensated acute heart failure, as assessed using the Prognostic Nutritional Index (PNI) and Controlling Nutritional Status (CONUT) score.
    Shirakabe A; Hata N; Kobayashi N; Okazaki H; Matsushita M; Shibata Y; Nishigoori S; Uchiyama S; Asai K; Shimizu W
    Heart Vessels; 2018 Feb; 33(2):134-144. PubMed ID: 28803356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease.
    Fukushima K; Kitada S; Komukai S; Kuge T; Matsuki T; Kagawa H; Tsujino K; Miki M; Miki K; Kida H
    Sci Rep; 2021 Jan; 11(1):1178. PubMed ID: 33441977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease.
    Kwon BS; Lee JH; Koh Y; Kim WS; Song JW; Oh YM; Lee SD; Lee SW; Lee JS; Lim CM; Choi CM; Huh JW; Hong SB; Shim TS; Jo KW
    Respir Med; 2019 Apr; 150():45-50. PubMed ID: 30961950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiological Persistence in Patients With Mycobacterium avium Complex Lung Disease: The Predictors and the Impact on Radiographic Progression.
    Pan SW; Shu CC; Feng JY; Wang JY; Chan YJ; Yu CJ; Su WJ
    Clin Infect Dis; 2017 Sep; 65(6):927-934. PubMed ID: 28541556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent Antibiotic Therapy for Recurrent Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.
    Jhun BW; Moon SM; Kim SY; Park HY; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.